Uncategorized

Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio

Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that the Board has appointed Dr Alessandro Riva, MD, as the Company’s new Chairman and CEO to accelerate the development of its innovative immunotherapy portfolio.

Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio Read More »

Entrevista al catedrático Javier Arias Díaz, Universidad Complutense de Madrid | Decano Javier Arias Díaz: “Ser médico implica tener habilidades interpersonales y éticas”

Javier Arias Díaz, Catedrático de Cirugía de la Universidad Complutense de Madrid (UCM), dialogó en exclusiva con IntraMed.

Entrevista al catedrático Javier Arias Díaz, Universidad Complutense de Madrid | Decano Javier Arias Díaz: “Ser médico implica tener habilidades interpersonales y éticas” Read More »

Scroll to Top